These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 37424193)

  • 1. Computational investigation of imidazo[2,1-b]oxazole derivatives as potential mutant BRAF kinase inhibitors: 3D-QSAR, molecular docking, molecular dynamics simulation, and ADMETox studies.
    Boutalaka M; El Bahi S; Alaqarbeh M; El Alaouy MA; Koubi Y; Khatabi KE; Maghat H; Bouachrine M; Lakhlifi T
    J Biomol Struct Dyn; 2024 Jul; 42(10):5268-5287. PubMed ID: 37424193
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Shirvani P; Fassihi A
    J Biomol Struct Dyn; 2022 Aug; 40(13):5965-5982. PubMed ID: 33475043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR Study, Molecular Docking and Molecular Dynamic Simulation of Aurora Kinase Inhibitors Derived from Imidazo[4,5-
    Tian YY; Tong JB; Liu Y; Tian Y
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of novel monoamine oxidase B (MAO-B) inhibitors by combined application of docking-based alignment, 3D-QSAR, ADMET prediction, molecular dynamics simulation, and MM_GBSA binding free energy.
    El Aissouq A; Chedadi O; Bouachrine M; Ouammou A; Khalil F
    J Biomol Struct Dyn; 2023 Jul; 41(10):4667-4680. PubMed ID: 35510607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico discovery of potent and selective Janus kinase 3 (JAK3) inhibitors through 3D-QSAR, covalent docking, ADMET analysis, molecular dynamics simulations, and binding free energy of pyrazolopyrimidine derivatives.
    Faris A; Hadni H; Ibrahim IM; Elhallaoui M
    J Biomol Struct Dyn; 2024 Jun; 42(9):4817-4833. PubMed ID: 37338041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico research on new sulfonamide derivatives as BRD4 inhibitors targeting acute myeloid leukemia using various computational techniques including 3D-QSAR, HQSAR, molecular docking, ADME/Tox, and molecular dynamics.
    Belghalia E; Ouabane M; El Bahi S; Rehman HM; Sbai A; Lakhlifi T; Bouachrine M
    J Biomol Struct Dyn; 2024 Oct; 42(17):9201-9219. PubMed ID: 37656159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D-QSAR-aided design of potent c-Met inhibitors using molecular dynamics simulation and binding free energy calculation.
    Balasubramanian PK; Balupuri A; Bhujbal SP; Cho SJ
    J Biomol Struct Dyn; 2019 May; 37(8):2165-2178. PubMed ID: 30044205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combined 3D-QSAR and molecular docking strategy to understand the binding mechanism of (V600E)B-RAF inhibitors.
    Ul-Haq Z; Mahmood U; Reza S
    Mol Divers; 2012 Nov; 16(4):771-85. PubMed ID: 23054531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Prediction of 3,5-Diaryl-1H-Pyrazole and spiropyrazolines derivatives as potential acetylcholinesterase inhibitors for alzheimer disease treatment by 3D-QSAR, molecular docking, molecular dynamics simulation, and ADME-Tox.
    El Alaouy MA; Alaqarbeh M; Ouabane M; Zaki H; ElBouhi M; Badaoui H; Moukhliss Y; Sbai A; Maghat H; Lakhlifi T; Bouachrine M
    J Biomol Struct Dyn; 2024 Nov; 42(18):9547-9560. PubMed ID: 37655700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on [5,6]-Fused Bicyclic Scaffolds Derivatives as Potent Dual B-RafV600E/KDR Inhibitors Using Docking and 3D-QSAR Approaches.
    Liu HC; Tang SZ; Lu S; Ran T; Wang J; Zhang YM; Xu AY; Lu T; Chen YD
    Int J Mol Sci; 2015 Oct; 16(10):24451-74. PubMed ID: 26501259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico design novel (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine derivatives as inhibitors for glycogen synthase kinase 3 based on 3D-QSAR, molecular docking and molecular dynamics simulation.
    He Q; Han C; Li G; Guo H; Wang Y; Hu Y; Lin Z; Wang Y
    Comput Biol Chem; 2020 Oct; 88():107328. PubMed ID: 32688011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational investigation of imidazopyridine analogs as protein kinase B (Akt1) allosteric inhibitors by using 3D-QSAR, molecular docking and molecular dynamics simulations.
    Gu X; Wang Y; Wang M; Wang J; Li N
    J Biomol Struct Dyn; 2021 Jan; 39(1):63-78. PubMed ID: 31838955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular docking, 3D QSAR and dynamics simulation studies of imidazo-pyrrolopyridines as janus kinase 1 (JAK 1) inhibitors.
    Itteboina R; Ballu S; Sivan SK; Manga V
    Comput Biol Chem; 2016 Oct; 64():33-46. PubMed ID: 27244086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics simulation, free energy calculation and structure-based 3D-QSAR studies of B-RAF kinase inhibitors.
    Yang Y; Qin J; Liu H; Yao X
    J Chem Inf Model; 2011 Mar; 51(3):680-92. PubMed ID: 21338122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive models for designing potent tyrosine kinase inhibitors in chronic myeloid leukemia for understanding its molecular mechanism of resistance by molecular docking and dynamics simulations.
    Melge AR; Kumar LG; K P; Nair SV; K M; C GM
    J Biomol Struct Dyn; 2019 Nov; 37(18):4747-4766. PubMed ID: 30580670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D-QSAR, docking and molecular dynamics simulations of novel Pyrazolo-pyridazinone derivatives as covalent inhibitors of FGFR1: a scientific approach for possible anticancer agents.
    Hamza S; Abid A; Khanum A; Chohan TA; Saleem H; Maqbool Khan K; Khurshid U; Butt J; Anwar S; Alafnan A; Ansari SA; Qayyum A; Raza A; Chohan TA
    J Biomol Struct Dyn; 2024 Mar; 42(5):2242-2256. PubMed ID: 37211823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Combined Pharmacophore Modeling, 3D QSAR and Virtual Screening Studies on Imidazopyridines as B-Raf Inhibitors.
    Xie H; Chen L; Zhang J; Xie X; Qiu K; Fu J
    Int J Mol Sci; 2015 May; 16(6):12307-23. PubMed ID: 26035757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-QSAR and molecular docking studies on derivatives of MK-0457, GSK1070916 and SNS-314 as inhibitors against Aurora B kinase.
    Zhang B; Li Y; Zhang H; Ai C
    Int J Mol Sci; 2010 Nov; 11(11):4326-47. PubMed ID: 21151441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor receptor (FGFR) inhibitors as anticancer agents: 3D-QSAR, molecular docking and dynamics simulation studies of 1, 6-naphthyridines and pyridopyrimidines.
    Modh DH; Modi SJ; Deokar H; Yadav S; Kulkarni VM
    J Biomol Struct Dyn; 2023 May; 41(8):3591-3606. PubMed ID: 35318898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Modeling Studies of
    Ghosh S; Keretsu S; Cho SJ
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.